Study of AVZO-021 in Patients With Advanced Solid Tumors
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc.
Pfizer
858 Therapeutics, Inc.
Klus Pharma Inc.
Cybrexa Therapeutics
Salubris Biotherapeutics Inc
Valerio Therapeutics
Pfizer
Corcept Therapeutics
Gilead Sciences
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Swedish Medical Center
Fred Hutchinson Cancer Center